[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

China Opioid-induced Constipation Market Research Report 2018

March 2018 | 116 pages | ID: CD9BA8749A4EN
QYResearch

US$ 3,400.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Opioid-induced Constipation market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

China plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Opioid-induced Constipation development status and future trend in China, focuses on top players in China, also splits Opioid-induced Constipation by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
  • AstraZeneca
  • Takeda Pharmaceutical
  • Valeant Pharmaceuticals International
  • Abbott
  • Bayer
  • Boehringer Ingelheim
  • C.B. Fleet
  • Cosmo Pharmaceuticals
  • Daewoong
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Ironwood Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • Mundipharma
  • Nektar Therapeutics
  • Pfizer
  • Progenics Pharmaceuticals
  • Shionogi
  • SLA Pharma
  • Sucampo
  • Synergy Pharmaceuticals
  • Theravance
Geographically, this report splits the China market into six regions,
  • South China
  • East China
  • Southwest China
  • Northeast China
  • North China
  • Central China
  • Northwest China
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
  • Solid
  • Liquid
On the basis of the end users/application, this report covers
  • Drugstore
  • Hospital
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
China Opioid-induced Constipation Market Research Report 2018

1 OPIOID-INDUCED CONSTIPATION OVERVIEW

1.1 Product Overview and Scope of Opioid-induced Constipation
1.2 Classification of Opioid-induced Constipation by Product Category
  1.2.1 China Opioid-induced Constipation Sales (K Units) Comparison by Type (2013-2025)
  1.2.2 China Opioid-induced Constipation Sales (K Units) Market Share by Type in 2017
  1.2.3 Solid
  1.2.4 Liquid
1.3 China Opioid-induced Constipation Market by Application/End Users
  1.3.1 China Opioid-induced Constipation Sales (K Units) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Drugstore
  1.3.3 Hospital
  1.3.4 Others
1.4 China Opioid-induced Constipation Market by Region
  1.4.1 China Opioid-induced Constipation Market Size (Million USD) Comparison by Region (2013-2025)
  1.4.2 South China Opioid-induced Constipation Status and Prospect (2013-2025)
  1.4.3 East China Opioid-induced Constipation Status and Prospect (2013-2025)
  1.4.4 Southwest China Opioid-induced Constipation Status and Prospect (2013-2025)
  1.4.5 Northeast China Opioid-induced Constipation Status and Prospect (2013-2025)
  1.4.6 North China Opioid-induced Constipation Status and Prospect (2013-2025)
  1.4.7 Central China Opioid-induced Constipation Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Opioid-induced Constipation (2013-2025)
  1.5.1 China Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2025)
  1.5.2 China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 CHINA OPIOID-INDUCED CONSTIPATION MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 China Opioid-induced Constipation Sales and Market Share of Key Players/Manufacturers (2013-2018)
2.2 China Opioid-induced Constipation Revenue and Share by Players/Manufacturers (2013-2018)
2.3 China Opioid-induced Constipation Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 China Opioid-induced Constipation Market Competitive Situation and Trends
  2.4.1 China Opioid-induced Constipation Market Concentration Rate
  2.4.2 China Opioid-induced Constipation Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Opioid-induced Constipation Manufacturing Base Distribution, Sales Area, Product Types

3 CHINA OPIOID-INDUCED CONSTIPATION SALES AND REVENUE BY REGION (2013-2018)

3.1 China Opioid-induced Constipation Sales (K Units) and Market Share by Region (2013-2018)
3.2 China Opioid-induced Constipation Revenue (Million USD) and Market Share by Region (2013-2018)
3.3 China Opioid-induced Constipation Price (USD/Unit) by Regions (2013-2018)

4 CHINA OPIOID-INDUCED CONSTIPATION SALES AND REVENUE BY TYPE/ PRODUCT CATEGORY (2013-2018)

4.1 China Opioid-induced Constipation Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
4.2 China Opioid-induced Constipation Revenue (Million USD) and Market Share by Type (2013-2018)
4.3 China Opioid-induced Constipation Price (USD/Unit) by Type (2013-2018)
4.4 China Opioid-induced Constipation Sales Growth Rate (%) by Type (2013-2018)

5 CHINA OPIOID-INDUCED CONSTIPATION SALES BY APPLICATION (2013-2018)

5.1 China Opioid-induced Constipation Sales (K Units) and Market Share by Application (2013-2018)
5.2 China Opioid-induced Constipation Sales Growth Rate (%) by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 CHINA OPIOID-INDUCED CONSTIPATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AstraZeneca
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioid-induced Constipation Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AstraZeneca Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Takeda Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Opioid-induced Constipation Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Takeda Pharmaceutical Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Valeant Pharmaceuticals International
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Opioid-induced Constipation Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Valeant Pharmaceuticals International Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Abbott
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Opioid-induced Constipation Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Abbott Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Bayer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Opioid-induced Constipation Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bayer Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Boehringer Ingelheim
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Opioid-induced Constipation Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Boehringer Ingelheim Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.6.4 Main Business/Business Overview
6.7 C.B. Fleet
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Opioid-induced Constipation Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 C.B. Fleet Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Cosmo Pharmaceuticals
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Opioid-induced Constipation Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Cosmo Pharmaceuticals Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Daewoong
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Opioid-induced Constipation Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Daewoong Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Daiichi Sankyo
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Opioid-induced Constipation Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Daiichi Sankyo Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
  6.10.4 Main Business/Business Overview
6.11 GlaxoSmithKline
6.12 Ironwood Pharmaceuticals
6.13 Johnson & Johnson
6.14 Merck
6.15 Mundipharma
6.16 Nektar Therapeutics
6.17 Pfizer
6.18 Progenics Pharmaceuticals
6.19 Shionogi
6.20 SLA Pharma
6.21 Sucampo
6.22 Synergy Pharmaceuticals
6.23 Theravance

7 OPIOID-INDUCED CONSTIPATION MANUFACTURING COST ANALYSIS

7.1 Opioid-induced Constipation Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioid-induced Constipation

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioid-induced Constipation Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioid-induced Constipation Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA OPIOID-INDUCED CONSTIPATION MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

11.1 China Opioid-induced Constipation Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
11.2 China Opioid-induced Constipation Sales (K Units) Forecast by Type (2018-2025)
11.3 China Opioid-induced Constipation Sales (K Units) Forecast by Application (2018-2025)
11.4 China Opioid-induced Constipation Sales (K Units) Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 METHODOLOGY AND DATA SOURCE

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Global and China Market Size (Million USD) Comparison (2013-2025)
Table Opioid-induced Constipation Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Opioid-induced Constipation Sales (K Units) by Application (2013-2025)
Figure Product Picture of Opioid-induced Constipation
Table China Opioid-induced Constipation Sales (K Units) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Opioid-induced Constipation Sales Volume Market Share by Types in 2017
Figure Solid Product Picture
Figure Liquid Product Picture
Figure China Opioid-induced Constipation Sales (K Units) Comparison by Application (2013-2025)
Figure China Sales Market Share (%) of Opioid-induced Constipation by Application in 2017
Figure Drugstore Examples
Table Key Downstream Customer in Drugstore
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Others Examples
Table Key Downstream Customer in Others
Figure South China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure East China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Northeast China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure North China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure Central China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2025)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table China Opioid-induced Constipation Sales of Key Players/Manufacturers (2013-2018)
Table China Opioid-induced Constipation Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Opioid-induced Constipation Sales Share (%) by Players/Manufacturers
Figure 2017 China Opioid-induced Constipation Sales Share (%) by Players/Manufacturers
Table China Opioid-induced Constipation Revenue by Players/Manufacturers (2013-2018)
Table China Opioid-induced Constipation Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Opioid-induced Constipation Revenue Market Share (%) by Players/Manufacturers
Figure 2017 China Opioid-induced Constipation Revenue Market Share (%) by Players/Manufacturers
Table China Market Opioid-induced Constipation Average Price of Key Players/Manufacturers (2013-2018)
Figure China Market Opioid-induced Constipation Average Price of Key Players/Manufacturers in 2017
Figure China Opioid-induced Constipation Market Share of Top 3 Players/Manufacturers
Figure China Opioid-induced Constipation Market Share of Top 5 Players/Manufacturers
Table China Players/Manufacturers Opioid-induced Constipation Manufacturing Base Distribution and Sales Area
Table China Players/Manufacturers Opioid-induced Constipation Product Category
Table China Opioid-induced Constipation Sales (K Units) by Regions (2013-2018)
Table China Opioid-induced Constipation Sales Share (%) by Regions (2013-2018)
Figure China Opioid-induced Constipation Sales Share (%) by Regions (2013-2018)
Figure China Opioid-induced Constipation Sales Market Share (%) by Regions in 2017
Table China Opioid-induced Constipation Revenue (Million USD) and Market Share by Regions (2013-2018)
Table China Opioid-induced Constipation Revenue Market Share (%) by Regions (2013-2018)
Figure China Opioid-induced Constipation Revenue Market Share (%) by Regions (2013-2018)
Figure China Opioid-induced Constipation Revenue Market Share (%) by Regions in 2017
Table China Opioid-induced Constipation Price (USD/Unit) by Regions (2013-2018)
Table China Opioid-induced Constipation Sales (K Units) by Type (2013-2018)
Table China Opioid-induced Constipation Sales Share (%) by Type (2013-2018)
Figure China Opioid-induced Constipation Sales Share (%) by Type (2013-2018)
Figure China Opioid-induced Constipation Sales Market Share (%) by Type in 2017
Table China Opioid-induced Constipation Revenue (Million USD) and Market Share by Type (2013-2018)
Table China Opioid-induced Constipation Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Opioid-induced Constipation by Type (2013-2018)
Figure Revenue Market Share of Opioid-induced Constipation by Type in 2017
Table China Opioid-induced Constipation Price (USD/Unit) by Types (2013-2018)
Figure China Opioid-induced Constipation Sales Growth Rate (%) by Type (2013-2018)
Table China Opioid-induced Constipation Sales (K Units) by Applications (2013-2018)
Table China Opioid-induced Constipation Sales Market Share (%) by Applications (2013-2018)
Figure China Opioid-induced Constipation Sales Market Share (%) by Application (2013-2018)
Figure China Opioid-induced Constipation Sales Market Share (%) by Application in 2017
Table China Opioid-induced Constipation Sales Growth Rate (%) by Application (2013-2018)
Figure China Opioid-induced Constipation Sales Growth Rate (%) by Application (2013-2018)
Table AstraZeneca Opioid-induced Constipation Basic Information List
Table AstraZeneca Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure AstraZeneca Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Takeda Pharmaceutical Opioid-induced Constipation Basic Information List
Table Takeda Pharmaceutical Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Takeda Pharmaceutical Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Valeant Pharmaceuticals International Opioid-induced Constipation Basic Information List
Table Valeant Pharmaceuticals International Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Valeant Pharmaceuticals International Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Abbott Opioid-induced Constipation Basic Information List
Table Abbott Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Abbott Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Abbott Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Abbott Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Bayer Opioid-induced Constipation Basic Information List
Table Bayer Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bayer Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bayer Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Bayer Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Boehringer Ingelheim Opioid-induced Constipation Basic Information List
Table Boehringer Ingelheim Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Boehringer Ingelheim Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table C.B. Fleet Opioid-induced Constipation Basic Information List
Table C.B. Fleet Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure C.B. Fleet Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Cosmo Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Cosmo Pharmaceuticals Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Cosmo Pharmaceuticals Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Daewoong Opioid-induced Constipation Basic Information List
Table Daewoong Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Daewoong Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Daewoong Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Daewoong Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table Daiichi Sankyo Opioid-induced Constipation Basic Information List
Table Daiichi Sankyo Opioid-induced Constipation Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Sales Market Share (%) in China (2013-2018)
Figure Daiichi Sankyo Opioid-induced Constipation Revenue Market Share (%) in China (2013-2018)
Table GlaxoSmithKline Opioid-induced Constipation Basic Information List
Table Ironwood Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Johnson & Johnson Opioid-induced Constipation Basic Information List
Table Merck Opioid-induced Constipation Basic Information List
Table Mundipharma Opioid-induced Constipation Basic Information List
Table Nektar Therapeutics Opioid-induced Constipation Basic Information List
Table Pfizer Opioid-induced Constipation Basic Information List
Table Progenics Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Shionogi Opioid-induced Constipation Basic Information List
Table SLA Pharma Opioid-induced Constipation Basic Information List
Table Sucampo Opioid-induced Constipation Basic Information List
Table Synergy Pharmaceuticals Opioid-induced Constipation Basic Information List
Table Theravance   Opioid-induced Constipation Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid-induced Constipation
Figure Manufacturing Process Analysis of Opioid-induced Constipation
Figure Opioid-induced Constipation Industrial Chain Analysis
Table Raw Materials Sources of Opioid-induced Constipation Major Players/Manufacturers in 2017
Table Major Buyers of Opioid-induced Constipation
Table Distributors/Traders List
Figure China Opioid-induced Constipation Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure China Opioid-induced Constipation Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Opioid-induced Constipation Price (USD/Unit) Trend Forecast (2018-2025)
Table China Opioid-induced Constipation Sales (K Units) Forecast by Type (2018-2025)
Figure China Opioid-induced Constipation Sales (K Units) Forecast by Type (2018-2025)
Figure China Opioid-induced Constipation Sales Volume Market Share Forecast by Type in 2025
Table China Opioid-induced Constipation Sales (K Units) Forecast by Application (2018-2025)
Figure China Opioid-induced Constipation Sales Volume Market Share Forecast by Application (2018-2025)
Figure China Opioid-induced Constipation Sales Volume Market Share Forecast by Application in 2025
Table China Opioid-induced Constipation Sales (K Units) Forecast by Regions (2018-2025)
Table China Opioid-induced Constipation Sales Volume Share Forecast by Regions (2018-2025)
Figure China Opioid-induced Constipation Sales Volume Share Forecast by Regions (2018-2025)
Figure China Opioid-induced Constipation Sales Volume Share Forecast by Regions in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories